Ovid Therapeutics: A Fast Growing Penny Stock to Watch

Ovid Therapeutics (OVID) is a biopharmaceutical company developing medicines for epilepsies and seizure-related disorders. Analysts recommend it as one of the best fast-growing penny stocks to buy, with a price target of $4. The company announced successful Phase 1 results for OV350, its first direct activator of the KCC2 transporter, with a favorable safety and tolerability profile. Ovid plans to advance its oral KCC2 portfolio, with OV4071 expected to initiate Phase 1/1b clinical trials in Q2 2026 for treating psychoses associated with neurodegenerative conditions.